SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-11-18 11:15
Tx date 2022-11-10 		$SKYE
Skye Bioscience, Inc. 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		877,500
Filed 2021-02-27 11:50
Tx date 2021-02-08 		$EMH
Emerald Health Therapeutics, Inc. 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+11,363 vol 		11,363
Filed 2021-02-27 11:49
Tx date 2016-08-08 		$EMH
Emerald Health Therapeutics, Inc. 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-27 11:49
Tx date 2021-02-08 		$EMH
Emerald Health Therapeutics, Inc. 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-11,363 vol 		0
Filed 2020-11-17 20:31
Tx date 2020-11-16 		$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+200,000 vol 		1,033,334
Filed 2020-11-17 20:26
Tx date 2020-11-16 		$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$20,000
+200,000 vol
$0.10 each 		2,061,333
Filed 2020-08-24 17:48
Tx date 2020-08-03 		$EMH
Emerald Health Therapeutics, Inc. 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$21,000
+100,000 vol
$0.21 each 		520,000
Filed 2020-07-10 20:36
Tx date 2020-07-10 		$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Holder: 642729 B.C. Ltd. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$12,500
+500,000 vol
$0.025 each 		500,000
Filed 2020-07-10 20:36
Tx date 2015-06-05 		$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Holder: 642729 B.C. Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-10 20:30
Tx date 2020-07-10 		$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$10,000
+400,000 vol
$0.025 each 		1,861,333
Filed 2020-02-27 14:55
Tx date 2020-02-06 		$EMH
Emerald Health Therapeutics, Inc. 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights 		$3,295
+11,363 vol
$0.29 each 		11,363
Filed 2020-02-27 14:54
Tx date 2016-08-08 		$EMH
Emerald Health Therapeutics, Inc. 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2020-02-27 14:43
Tx date 2020-02-06 		$EMH
Emerald Health Therapeutics, Inc. 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$21,750
+75,000 vol
$0.29 each 		420,000
Filed 2019-10-31 20:58
Tx date 2019-10-28 		$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+150,000 vol 		1,026,072
Filed 2019-08-15 17:29
Tx date 2019-08-14 		$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+500,000 vol 		833,334
Filed 2019-08-15 17:22
Tx date 2019-08-14 		$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$25,000
+500,000 vol
$0.05 each 		1,461,333
Filed 2019-08-07 17:18
Tx date 2019-07-19 		$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-60,300
-180,000 vol
$0.335 each 		345,000
Filed 2019-07-26 13:33
Tx date 2019-07-19 		$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-60,300
-180,000 vol
$0.335 each
Filed 2019-07-26 13:33
Tx date 2019-07-19 		$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-60,300
-180,000 vol
$0.335 each 		345,000
Filed 2019-07-10 13:54
Tx date 2017-12-22 		$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$318,750
+75,000 vol
$4.25 each 		325,000
Filed 2019-07-04 18:24
Tx date 2019-04-03 		$EMH
Emerald Health Therapeutics, Inc. (formerly T-Bird Pharma Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$830,000
+200,000 vol
$4.15 each 		450,000
Filed 2019-06-24 14:43
Tx date 2019-06-24 		$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-37,180
-169,000 vol
$0.22 each 		876,072
Filed 2019-06-13 10:57
Tx date 2019-04-01 		$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) 		Rai, Sukhwinder Singh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$24,000
+400,000 vol
$0.06 each 		1,045,072